Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$9.8M
Prescriptions
461
$21,212.47 per claim
Patients
150
175 prescribers
Total spending, 2024
$9.8M
$65,192.99 per patient
Medicare prescription drug plans paid $9.8M for Augtyro in 2024, for 461 prescriptions and refills to 150 patients. The average cost per claim was $21,212.47.
California had the highest Medicare cost for Augtyro in 2024: $1.4M for 56 claims, followed by New York ($864K).
Ticiana B Leal, medical oncology in Atlanta, GA, had the highest Medicare cost for Augtyro in 2024: 16 claims costing $324K.
Augtyro is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as BMS Primarycare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Ticiana B Leal Atlanta, GA | Medical Oncology | 16 | Under 11 | $324K |
| Jerome H Goldschmidt Jr. Christiansburg, VA | Hematology-Oncology | 13 | Under 11 | $254K |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2024 | 175 | 461 | 150 | $9.8M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| BMS Primarycare BMY |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| 461 |
| $9.8M |